Diane E. Gingrich

1.1k citations

25 papers · 678 indexed · h-index 15

Impact in

Oncology top 10%
- Cytokine Signaling Pathways and Interactions
Organic Chemistry top 10%
- Quinazolinone synthesis and applications

Papers in ⓘ

Oncology 11
- Cytokine Signaling Pathways and Interactions 5
- Cancer Treatment and Pharmacology 3
Genetics 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3

Co-authors: Bruce Ruggeri (10 shared papers)Thelma S. Angeles (12 shared papers)Mark S. Albom (11 shared papers)Mark A. Ator (10 shared papers)Bruce D. Dorsey (10 shared papers)Roberta L. Dorow (4 shared papers)Lisa D. Aimone (9 shared papers)Paweł Dobrzański (5 shared papers)
Journals: Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Molecular Cancer Therapeutics (2 papers)Tetrahedron Letters (1 paper)Chemical Communications (1 paper)
Partner nations: United States Italy France

In The Last Decade

Diane E. Gingrich

25 papers receiving 632 citations

Peers

Countries citing papers authored by Diane E. Gingrich

Since Specialization

Citations

This map shows the geographic impact of Diane E. Gingrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane E. Gingrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane E. Gingrich more than expected).

Fields of papers citing papers by Diane E. Gingrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane E. Gingrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane E. Gingrich. The network helps show where Diane E. Gingrich may publish in the future.

Co-authors

The 25 scholars most cited alongside Diane E. Gingrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Diane E. Gingrich Line = papers co-authored together Diane E. Gingrich links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy Current Medicinal Chemistry ·T. L. UNDERINER, Bruce Ruggeri, Diane E. Gingrich	2004	108
2	A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis Arthritis Research & Therapy ·Kristine L. Stump, Lily Lu, Paweł Dobrzański, Cynthia Serdikoff, Diane E. Gingrich, Benjamin J. Dugan, Thelma S. Angeles, Mark S. Albom, Mark A. Ator, Bruce D. Dorsey, Bruce Ruggeri, Matthew M. Seavey	2011	65
3	CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers Molecular Cancer Therapeutics ·Mangeng Cheng, Matthew R. Quail, Diane E. Gingrich, Gregory R. Ott, Lihui Lü, Weihua Wan, Mark S. Albom, Thelma S. Angeles, Lisa D. Aimone, Flavio Cristofani, Rodolfo Machiorlatti, Cristina Abele, Mark A. Ator, Bruce D. Dorsey, Giorgio Inghirami, Bruce Ruggeri	2011	59
4	Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2 The Journal of Immunology ·Lily Lu, Kristine L. Stump, Nate H. Wallace, Paweł Dobrzański, Cynthia Serdikoff, Diane E. Gingrich, Benjamin J. Dugan, Thelma S. Angeles, Mark S. Albom, Jennifer L. Mason, Mark A. Ator, Bruce D. Dorsey, Bruce Ruggeri, Matthew M. Seavey	2011	59
5	A New Class of Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Structure−Activity Relationships for a Series of 9-Alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-a]pyrrolo[3,4-c]carbazole-5-ones and the Identification of CEP-5214 and Its Dimethylglycine Ester Prodrug Clinical Candidate CEP-7055 Journal of Medicinal Chemistry ·Diane E. Gingrich, D. Rajagopala Reddy, Mohamed Iqbal, J. B. Singh, Lisa D. Aimone, Thelma S. Angeles, Mark S. Albom, Shi Yang, Mark A. Ator, Sheryl L. Meyer, Candy Robinson, Bruce Ruggeri, Craig A. Dionne, Jeffry L. Vaught, John P. Mallamo, Robert L. Hudkins	2003	57
6	A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-a]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779 Journal of Medicinal Chemistry ·Benjamin J. Dugan, Diane E. Gingrich, Eugen F. Mesaros, Karen L. Milkiewicz, Matthew A. Curry, Allison L. Zulli, Paweł Dobrzański, Cynthia Serdikoff, Mahfuza Jan, Thelma S. Angeles, Mark S. Albom, Jennifer L. Mason, Lisa D. Aimone, Sheryl L. Meyer, Zeqi Huang, Kevin J. Wells‐Knecht, Mark A. Ator, Bruce Ruggeri, Bruce D. Dorsey	2012	53
7	Discovery of an Orally Efficacious Inhibitor of Anaplastic Lymphoma Kinase Journal of Medicinal Chemistry ·Diane E. Gingrich, Joseph G. Lisko, Matthew A. Curry, Mangeng Cheng, Matthew R. Quail, Lihui Lü, Weihua Wan, Mark S. Albom, Thelma S. Angeles, Lisa D. Aimone, R. Curtis Haltiwanger, Kevin J. Wells‐Knecht, Gregory R. Ott, Arup K. Ghose, Mark A. Ator, Bruce Ruggeri, Bruce D. Dorsey	2012	31
8	2,7-Disubstituted-pyrrolo[2,1-f][1,2,4]triazines: New Variant of an Old Template and Application to the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors with in Vivo Antitumor Activity Journal of Medicinal Chemistry ·Gregory R. Ott, Gregory J. Wells, Tho V. Thieu, Matthew R. Quail, Joseph G. Lisko, Eugen F. Mesaros, Diane E. Gingrich, Arup K. Ghose, Weihua Wan, Lihui Lü, Mangeng Cheng, Mark S. Albom, Thelma S. Angeles, Zeqi Huang, Lisa D. Aimone, Mark A. Ator, Bruce Ruggeri, Bruce D. Dorsey	2011	31
9	A Novel Preparation of Scalemic N-Methyl-.alpha.-Amino Acids The Journal of Organic Chemistry ·Roberta L. Dorow, Diane E. Gingrich	1995	27
10	Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease Drug Development Research ·Mary J. Savage, Diane E. Gingrich	2009	26
11	Development and Scale-Up of an Optimized Route to the ALK Inhibitor CEP-28122 Organic Process Research & Development ·Shawn P. Allwein, Renee C. Roemmele, James J. Haley, Dale R. Mowrey, Daniel E. Petrillo, James J. Reif, Diane E. Gingrich, Roger P. Bakale	2011	25
12	Antineoplastic agents. Part 395.1 Isolation and structure of agelagalastatin from the Papua New Guinea marine sponge Agelas sp. Chemical Communications ·George R. Pettit, Jun‐Ping Xu, Diane E. Gingrich, Michael D. Williams, Dennis L. Doubek, Jean‐Charles Chapuis, Jean M. Schmidt	1999	19
13	Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases Bioorganic & Medicinal Chemistry Letters ·Craig A. Zificsak, Diane E. Gingrich, Henry J. Breslin, Derek Dunn, Karen L. Milkiewicz, Jay Theroff, Tho V. Thieu, Ted L. Underiner, Linda R. Weinberg, Lisa D. Aimone, Mark S. Albom, Jennifer L. Mason, Lisa Saville, Jean Husten, Thelma S. Angeles, James P. Finn, Mahfuza Jan, Teresa M. O’Kane, Paweł Dobrzański, Bruce D. Dorsey	2011	18
14	2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: Modification of target structure to minimize reactive metabolite formation Bioorganic & Medicinal Chemistry Letters ·Linda R. Weinberg, Mark S. Albom, Thelma S. Angeles, Henry J. Breslin, Diane E. Gingrich, Zeqi Huang, Joseph G. Lisko, Jennifer L. Mason, Karen L. Milkiewicz, Tho V. Thieu, Ted L. Underiner, Gregory J. Wells, Kevin J. Wells‐Knecht, Bruce D. Dorsey	2011	17
15	Synthesis, Modeling, and In Vitro Activity of (3‘S)-epi-K-252a Analogues. Elucidating the Stereochemical Requirements of the 3‘-Sugar Alcohol on trkA Tyrosine Kinase Activity Journal of Medicinal Chemistry ·Diane E. Gingrich, Shi Yang, George Gessner, Thelma S. Angeles, Robert L. Hudkins	2005	17
16	Inhibition of metalloproteinase by futoenone derivatives Bioorganic & Medicinal Chemistry Letters ·Li-An Yeh, James Chen, Frans Baculi, Diane E. Gingrich, T. Y. Shen	1995	13
17	A comparison of the determination and speciation of inorganic arsenic using general HPLC methodology with UV, MS and MS/MS detection Journal of Chromatography B ·Gregory Gilmartin, Diane E. Gingrich	2018	12
18	Synthesis and kinase inhibitory activity of 3′-(S)-epi-K-252a Bioorganic & Medicinal Chemistry Letters ·Diane E. Gingrich, Robert L. Hudkins	2002	12
19	A novel, one-pot preparation ofN-methyl-α-amino acid dipeptides from oxazolidinones and amino acids Tetrahedron Letters ·Roberta L. Dorow, Diane E. Gingrich	1999	10
20	2,7-Disubstituted-Pyrrolotriazine Kinase Inhibitors with an Unusually High Degree of Reactive Metabolite Formation Chemical Research in Toxicology ·Kevin J. Wells‐Knecht, Gregory R. Ott, Mangeng Cheng, Gregory J. Wells, Henry J. Breslin, Diane E. Gingrich, Linda R. Weinberg, Eugen F. Mesaros, Zeqi Huang, Mehran Yazdanian, Mark A. Ator, Lisa D. Aimone, Kelli S. Zeigler, Bruce D. Dorsey	2011	8

About Diane E. Gingrich

Diane E. Gingrich is a scholar working on Oncology, Genetics, Neurology, Biotechnology and Rheumatology, having authored 25 papers that have together received 678 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), Chemical Synthesis and Analysis (5 papers), Neuroblastoma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Oncology (251 citations), Organic Chemistry (226 citations), Toxicology (22 citations), Genetics (58 citations) and Rheumatology (77 citations). Diane E. Gingrich has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Bruce Ruggeri, Thelma S. Angeles, Mark S. Albom, Mark A. Ator, Bruce D. Dorsey, Roberta L. Dorow, Lisa D. Aimone, Paweł Dobrzański, Mary J. Savage and Robert L. Hudkins. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Molecular Cancer Therapeutics, Tetrahedron Letters and Chemical Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact